Clinical trial

Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving…

NCT00294658 · University of Alabama at Birmingham, Other · Completed

Key facts

NCT number NCT00294658
Title Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Official title A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomatous Myasthenia Gravis (MG) Patients Receiving Prednisone
Lead sponsor University of Alabama at Birmingham, Other
Collaborators National Institute of Neurological Disorders and Stroke (NINDS) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Myasthenia Gravis
Intervention type Drug, Procedure
Interventions thymectomy plus prednisone, prednisone alone
Enrollment 126
Start date Jun 1, 2006
Primary completion Nov 1, 2015
Completion Dec 1, 2015
First posted Feb 22, 2006
Last update posted May 23, 2017
Countries Argentina, Australia, Brazil, Canada, Chile, Germany, Italy, Japan, Mexico, Netherlands, Poland, Portugal and 6 more

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies